(VIANEWS) – Crown Crafts (CRWS), Dreyfus Strategic Municipals (LEO), Phibro Animal Health Corporation (PAHC) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Crown Crafts (CRWS) | 6.05% | 2024-02-16 07:43:05 |
| Dreyfus Strategic Municipals (LEO) | 4.13% | 2024-02-12 04:41:07 |
| Phibro Animal Health Corporation (PAHC) | 3.98% | 2024-02-18 23:47:07 |
| Novartis AG (NVS) | 3.64% | 2024-02-28 15:57:37 |
A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Crown Crafts (CRWS) – Dividend Yield: 6.05%
Crown Crafts’s last close was $5.90, 1.17% under its 52-week high of $5.97. Intraday change was 3.51%.
Crown Crafts, Inc., through its subsidiaries, operates in the consumer products industry in the United States and internationally. It provides infant, toddler, and juvenile products, including infant and toddler beddings; blankets and swaddle blankets; nursery and toddler accessories; room décors; reusable and disposable bibs; burp cloths; hooded bath towels and washcloths; reusable and disposable placemats, and floor mats; disposable toilet seat covers and changing mats; developmental toys; feeding and care goods; and other infant, toddler, and juvenile soft goods. The company sells its products primarily to mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs and internet-based retailers through a network of sales force and independent commissioned sales representatives. Crown Crafts, Inc. was incorporated in 1957 and is headquartered in Gonzales, Louisiana.
Earnings Per Share
As for profitability, Crown Crafts has a trailing twelve months EPS of $0.43.
PE Ratio
Crown Crafts has a trailing twelve months price to earnings ratio of 13.72. Meaning, the purchaser of the share is investing $13.72 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.88%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Dec 14, 2023, the estimated forward annual dividend rate is 0.32 and the estimated forward annual dividend yield is 6.05%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28.9%, now sitting on 81.87M for the twelve trailing months.
Yearly Top and Bottom Value
Crown Crafts’s stock is valued at $5.90 at 02:15 EST, below its 52-week high of $5.97 and way higher than its 52-week low of $4.11.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Crown Crafts’s EBITDA is 1.
More news about Crown Crafts.
2. Dreyfus Strategic Municipals (LEO) – Dividend Yield: 4.13%
Dreyfus Strategic Municipals’s last close was $6.01, 9.35% below its 52-week high of $6.63. Intraday change was 0.5%.
BNY Mellon Strategic Municipals, Inc. is a closed ended fixed income mutual fund launched and managed by BNY Mellon Investment Adviser, Inc. It invests in the fixed income markets of the United States. The fund primarily invests in investment grade municipal bonds, the income from which is exempt from federal income tax. It employs fundamental analysis to create its portfolio. The fund was formerly known as Dreyfus Strategic Municipals, Inc. BNY Mellon Strategic Municipals, Inc. was formed on September 23, 1987 and is domiciled in the United States.
Earnings Per Share
As for profitability, Dreyfus Strategic Municipals has a trailing twelve months EPS of $0.04.
PE Ratio
Dreyfus Strategic Municipals has a trailing twelve months price to earnings ratio of 150.25. Meaning, the purchaser of the share is investing $150.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.31%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Feb 13, 2024, the estimated forward annual dividend rate is 0.25 and the estimated forward annual dividend yield is 4.13%.
More news about Dreyfus Strategic Municipals.
3. Phibro Animal Health Corporation (PAHC) – Dividend Yield: 3.98%
Phibro Animal Health Corporation’s last close was $12.07, 26.94% under its 52-week high of $16.52. Intraday change was -0.74%.
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.
Earnings Per Share
As for profitability, Phibro Animal Health Corporation has a trailing twelve months EPS of $0.37.
PE Ratio
Phibro Animal Health Corporation has a trailing twelve months price to earnings ratio of 32.62. Meaning, the purchaser of the share is investing $32.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.49%.
Moving Average
Phibro Animal Health Corporation’s worth is above its 50-day moving average of $11.34 and below its 200-day moving average of $12.71.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 5, 2024, the estimated forward annual dividend rate is 0.48 and the estimated forward annual dividend yield is 3.98%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.2%, now sitting on 982.01M for the twelve trailing months.
More news about Phibro Animal Health Corporation.
4. Novartis AG (NVS) – Dividend Yield: 3.64%
Novartis AG’s last close was $102.22, 6.03% below its 52-week high of $108.78. Intraday change was -0.86%.
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. It offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
Earnings Per Share
As for profitability, Novartis AG has a trailing twelve months EPS of $4.1.
PE Ratio
Novartis AG has a trailing twelve months price to earnings ratio of 24.94. Meaning, the purchaser of the share is investing $24.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.15%.
More news about Novartis AG.
